Home Compare COHR vs GMED
Stock Comparison · Cheaper and stronger

Coherent vs Globus Medical: Which Stock Looks Stronger in 2026?

Globus Medical holds the cleaner structural position, with the lead spread across valuation and profitability. Coherent does not offset that deficit through any equally strong structural edge elsewhere. The market setup is mixed, without a decisive signal in either direction. The market is not adding a decisive signal either way — the structural read carries the weight.

The comparison is based on similar long-term financial trajectories, not sector labels.

Updated 2026-04-05

The clearest separation starts in valuation, but profitability adds another real layer to the result. Globus Medical, Inc. leads by 46 points on the overall comparison score.

Trajectory Similarity
0.59
Moderately similar
Peer-set rank: #13
within Coherent Corp.'s functional peer set

These two companies are linked by measured long-term financial trajectory similarity within the selected peer universe.

This level of similarity points to a meaningful structural match, though not a tight one.

The strongest overlap appears in margin trend and recent revenue growth.

Similarity drivers
margin trendrecent revenue growth
What reduces the match
revenue growth trajectory
How to read the score
0.85–1.00 · Very similar0.70–0.84 · Similar0.55–0.69 · Moderately similarbelow 0.55 · Loose match
Peer-Relative Score
COHR
Coherent Corp.
23
Peer-Score
Signal qualityMedium
vs
GMED
Globus Medical, Inc.
69
Peer-Score
Signal qualityHigh

Scores reflect position relative to comparable companies with similar long-term financial trajectories.

Pricing and operating quality both support the lead here.

Dimension spread: COHR vs GMED Profitability 5 56 Stability 31 44 Valuation 8 81 Growth 62 95 COHR GMED
Gap Ranking
#1 Valuation +73
#2 Profitability +51
#3 Growth +33
#4 Stability +13
Price Setup

Left means cheaper relative valuation. Higher means stronger structure.

Price setup map for COHR and GMED Stronger + cheaper Stronger + richer Weaker + cheaper Weaker + richer COHRGMED Relative valuation Structural strength

Globus Medical, Inc. looks stronger on relative valuation, while the broader price setup remains mixed.

Valuation position uses peer-relative PE percentile (idx_pct_pe) where available.

Relative Position vs Comparable Companies
Valuation
Globus Medical, Inc. ranks near the top of the group on valuation; Coherent Corp. sits in the weaker half.
Profitability
Globus Medical, Inc. sits in the stronger part of the group on profitability, while Coherent Corp. is closer to mid-pack.
Valuation — Dominant Gap
COHR
8
GMED
81
Gap+73in favour of GMED

The multiple-based pricing edge comes from a forward P/E that is 17.1 turns lower.

What else supports the lead

Profitability gives the lead a second hard layer of support, with a 12.6-point operating margin advantage.

What this means for the comparison

The lead is built on both valuation and profitability, making it broader than a single-dimension result.

Explore full peer positioning in AssetNext

Break down the COHR vs GMED comparison across all dimensions with the full interactive tool.

Explore full breakdown →
Similar valuation-and-profitability comparisons

Explore how COHR and GMED each compare against other companies in their peer groups.

Rule-based, descriptive analysis only. Derived from peer percentile dimensions. Not investment advice. Peer groups are determined algorithmically based on structural similarity — not by sector classification alone.

How AssetNext Peer Scores Work

AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.

Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.

Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.